ALT Altimmune: Rasio total nilai perusahaan marang pendapatan

Altimmune Inc (ALT) - logo korporat

Altimmune, Inc. (ALT) maintains high operational efficiency through an optimized contract manufacturing network. The company's enterprise value-to-revenue valuation reflects current trends, where 1515666.67 represents the current metric level. However, success depends on the outcome of clinical trials and market demand. The environmental footprint remains minimal due to outsourcing and adherence to laboratory safety standards.

Multiplikator EV/Sales Altimmune Corp (ALT): kanggo periode 23.11.2025 - 20.11.2026

Rincian metrik keuangan lan pasar Altimmune (ALT)

- rega pasar lan target rega analis:
Pambiji fundamental perusahaan:ALT (altimmune.com)
Barang unggulan altimmune.com

This ratio determines the market value of the business, accounting for net debt relative to annual turnover. By analyzing the EV-to-revenue metric of the company, an investor assesses the efficiency of asset monetization without distortions from the capital structure. The metric is calculated as the ratio of the total enterprise value to sales volume. For Altimmune, Inc. (ALT), this indicator reflects the capital intensity of peptide development. Dependence on external contract manufacturers makes cost monitoring critical for assessing operational resilience.

Analisis pesaing

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)